Single-Dose And Multiple-Dose Safety And Tolerability Study Of PF-04856883 In Type 2 Diabetic Adult Females

NCT01301456 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus
Diabetes Mellitus, Type 2
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases

Interventions

BIOLOGICAL: Placebo
BIOLOGICAL: PF-04856883
BIOLOGICAL: PF-04856883
BIOLOGICAL: PF-04856883
BIOLOGICAL: Placebo
BIOLOGICAL: PF-04856883
BIOLOGICAL: PF-04856883
BIOLOGICAL: PF-04856883
BIOLOGICAL: Placebo
BIOLOGICAL: PF-04856883
BIOLOGICAL: PF-04856883
BIOLOGICAL: PF-04856883
BIOLOGICAL: PF-04856883

Sponsor

Pfizer